The Framingham-based New England Compounding Center produced a steroid linked to a deadly meningitis outbreak, which has killed 12 people and infected 130 others across 10 states.
New England Compunding Center, which has been tied to the national memingitis outbreak, may have misled regulators and completed work beyond its state license, said Massachusetts Gov. Deval Patrick. The Framingham-based specialty pharmacy produced a steroid, that health officials believe killed 12 people, infected 130 others across 10 states, with a fungal meningitis. The governor told reporters Wednesday, "What they were supposed to be doing is filling specific prescriptions for specific patients, as I think any of us would understand a pharmacy to do. What they were doing instead is making big batches and selling them out of state as a manufacturer would and that is certainly outside of their state license." While the compounding …
As the death toll rises, and more individuals are diagnosed with meningitis due to a steroid produced by New England Compounding Center in Framingham, a Boston law firm is investigating claims and suits.
Wednesday, October 10, 2012
Sugarman, Rogers, Barshak & Cohen, a Boston-based trial firm, is investigating claims by individuals, who have contracted fungal meningitis from the use of methylprednisolone acetate, a corticosteroid injected into the spine for relief of severe back pain. As of midnight Wednesday, more than 110 individuals have contracted fungal meningitis and 11 individuals have died, in 11 states. Patients who have received steroid injections, since early summer, are urged to see a doctor if they develop symptoms like severe headaches, fever, nausea, difficulty with balance or slurred speech. The contaminated steroid was sold by New England Compounding Center, a specialty pharmacy based in Framingham. Compounding pharmacies prepare drug mixtures and …